EGEPO.E — Nasmed Ozel Saglik Hizmetleri Ticaret AS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
TRY3.59bn
Enterprise Value
TRY3.49bn
Revenue
TRY1.01bn

Annual income statement for Nasmed Ozel Saglik Hizmetleri Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	115	170	499	891	1,009
Cost of Revenue
Gross Profit	41.9	40.1	78.7	250	235
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	76.9	144	524	846	1,127
Operating Profit	37.7	25.3	-25.4	45.3	-118
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	33.4	18.3	-139	137	-37.3
Provision for Income Taxes
Net Income After Taxes	32.9	17.4	-146	133	-23.7
Net Income Before Extraordinary Items
Net Income	32.9	17.4	-146	133	-23.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	32.9	17.4	-146	133	-23.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.265	0.141	-1.16	1.08	-0.173
Dividends per Share